<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2085</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>ROLE OF SALIVARY SECRETORY LEUKOCYTE PROTEASE INHIBITOR IN HIV:A REVIEW&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Charanthimath</surname><given-names>Shivayogi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Keluskar</surname><given-names>Vaishali</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bagewadi</surname><given-names>Anjana</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bhat</surname><given-names>Kishor</given-names></name></contrib></contrib-group><volume>)</volume><issue/><fpage>121</fpage><lpage>126</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Saliva is a promising option for diagnosing certain disorders and monitoring the evolution of certain&#13;
pathologies or the dosage of medicines or drugs. Its advantages as a diagnostic tool include its being easy&#13;
to obtain and the positive correlation between many parameters in serum and saliva. Saliva plays an&#13;
essential r__ampersandsignocirc;le in maintaining the integrity of the oral structures, in personal relationships, in the digestion&#13;
and in controlling oral infection.&#13;
Human secretory leukocyte protease inhibitor is a cationic protein in saliva has been found to be the most&#13;
potent anti-HIV-1 factor among several innate inhibitory molecules namely, virus-specific antibodies,&#13;
mucins, and thrombospondins, identified and purified from saliva. This review includes the role of slpi as&#13;
a anti HIV factor, there by reducing the risk of oral transmission of HIV and also antiprotease,&#13;
bactericidal and antifungal activity are also discussed.&#13;
</p></abstract><kwd-group><kwd>saliva.HIV</kwd><kwd> SLPI</kwd></kwd-group></article-meta></front></article>
